PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
about
Melanoma Brain Metastasis: Mechanisms, Models, and MedicineCopy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants.Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites.Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.Molecular insights into melanoma brain metastases.Melanoma central nervous system metastases: current approaches, challenges, and opportunities.The Microenvironmental Landscape of Brain Tumors.Management of intracranial melanomas in the era of precision medicine.The biology and therapeutic management of melanoma brain metastases.Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?Reactive Astrocytes in Brain Metastasis.Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.Genome-wide profiling of the PIWI-interacting RNA-mRNA regulatory networks in epithelial ovarian cancers.Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion.Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures.Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues.Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives.New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model.Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter
P2860
Q28069421-A264C4F6-82E1-4A56-BA77-E8D9A6ABCD16Q31105539-66317D4D-3CF0-4218-B5D1-BE501792AA10Q35812429-2B59ED6D-8E11-4A5E-B1CD-D2DA3B56F928Q38660042-60804873-3639-43F0-BBFE-4692214B69A2Q38764364-87653EF8-A339-40AA-AE69-CBB59BAD68ADQ38807942-12CB3802-E05C-47C1-B8F1-014A9A64D7D1Q39178065-43FE41CB-B69D-4859-812A-53515EE7718CQ44959749-B2F60255-494C-4611-A448-800FDBA2A53AQ47247953-C0F10E3D-AD39-44FF-9F3D-781DEDF7C984Q47573654-B5C1AE5D-2B0F-4BE3-B183-E752ABB0D509Q47875808-83C5D2DD-8ABF-43B5-AD99-0C235BF5AF4DQ48108646-A51D8FA1-203B-426A-850F-08DDB50A8F4CQ48269600-EB17317F-B389-4C6F-838C-BD2AF8F9E42EQ54962187-B97B5F33-7A60-40CC-99B4-85F5724E27EDQ55172170-FCAFDD4F-A1BB-4C01-A14C-61CAB58F5721Q55254148-20E71A58-5748-418C-9167-B781BAF029AFQ55417928-02BD2A7B-6D60-43E7-80C9-87B733BC6A96Q55513422-C81B8EA9-1384-43C5-B1ED-19437E18FC94Q56673276-062DD760-A6A0-441B-B9BF-5CD7D4FEACD2
P2860
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
@ast
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
@en
type
label
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
@ast
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
@en
prefLabel
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
@ast
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
@en
P2093
P2860
P1476
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis.
@en
P2093
Christopher R Zito
David L Rimm
Fabio Parisi
Harriet M Kluger
Lucia B Jilaveanu
Marcus W Bosenberg
Meaghan L Barr
Robert S Kerbel
Ruth Halaban
William Cruz-Munoz
P2860
P304
P356
10.1158/1078-0432.CCR-14-0861
P407
P577
2014-10-14T00:00:00Z